<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Angiosoma Inc — News on 6ix</title>
<link>https://6ix.com/company/angiosoma-inc</link>
<description>Latest news and press releases for Angiosoma Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 02 Aug 2022 16:35:38 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/angiosoma-inc" rel="self" type="application/rss+xml" />
<item>
<title>GlobeStar Therapeutics Corporation Update on Recent Activity</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-update-on-recent-activity</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-update-on-recent-activity</guid>
<pubDate>Tue, 02 Aug 2022 16:35:38 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Update on Recent Activity.</description>
</item>
<item>
<title>CEOs Presenting at the Emerging Growth Conference on April 27; Register Now</title>
<link>https://6ix.com/company/angiosoma-inc/news/ceos-presenting-at-the-emerging-growth-conference-on-april-27-register-now</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/ceos-presenting-at-the-emerging-growth-conference-on-april-27-register-now</guid>
<pubDate>Tue, 26 Apr 2022 11:02:05 GMT</pubDate>
<description>CEOs Presenting at the Emerging Growth Conference on April 27; Register Now.</description>
</item>
<item>
<title>CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract</title>
<link>https://6ix.com/company/angiosoma-inc/news/correcting-and-replacing-globestar-therapeutics-corporation-awards-new-york-bay-capital-llc-investment-banking-contract</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/correcting-and-replacing-globestar-therapeutics-corporation-awards-new-york-bay-capital-llc-investment-banking-contract</guid>
<pubDate>Tue, 01 Mar 2022 18:20:52 GMT</pubDate>
<description>CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract.</description>
</item>
<item>
<title>GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-awards-new-york-bay-capital-llc-investment-banking-contract</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-awards-new-york-bay-capital-llc-investment-banking-contract</guid>
<pubDate>Tue, 01 Mar 2022 15:23:19 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract.</description>
</item>
<item>
<title>GlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s Disease</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-addresses-the-potential-link-between-neurodegenerative-disease-and-parkinsons-disease</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-addresses-the-potential-link-between-neurodegenerative-disease-and-parkinsons-disease</guid>
<pubDate>Fri, 04 Feb 2022 11:13:24 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s Disease.</description>
</item>
<item>
<title>OTC Markets Group Welcomes New OTCQB Companies – October 18</title>
<link>https://6ix.com/company/angiosoma-inc/news/otc-markets-group-welcomes-new-otcqb-companies-october-18-1</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/otc-markets-group-welcomes-new-otcqb-companies-october-18-1</guid>
<pubDate>Mon, 18 Oct 2021 11:00:00 GMT</pubDate>
<description>OTC Markets Group Welcomes New OTCQB Companies – October 18.</description>
</item>
<item>
<title>GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-has-been-upgraded-to-the-qb-tier-on-otc-markets</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-has-been-upgraded-to-the-qb-tier-on-otc-markets</guid>
<pubDate>Mon, 11 Oct 2021 12:30:26 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets.</description>
</item>
<item>
<title>GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-additional-progress-toward-a-us-based-clinical-trial</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-additional-progress-toward-a-us-based-clinical-trial</guid>
<pubDate>Mon, 04 Oct 2021 13:00:16 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial..</description>
</item>
<item>
<title>GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis</title>
<link>https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-files-new-8k-statement-focused-on-progress-market-acceptance-and-a-potential-game-changing-drug-for-multiple-sclerosis</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/globestar-therapeutics-corporation-files-new-8k-statement-focused-on-progress-market-acceptance-and-a-potential-game-changing-drug-for-multiple-sclerosis</guid>
<pubDate>Mon, 20 Sep 2021 20:05:20 GMT</pubDate>
<description>GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis.</description>
</item>
<item>
<title>AngioSoma, Inc. Appoints New CEO</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-appoints-new-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-appoints-new-ceo</guid>
<pubDate>Fri, 09 Dec 2016 14:01:42 GMT</pubDate>
<description>AngioSoma, Inc. Appoints New CEO.</description>
</item>
<item>
<title>AngioSoma, Inc. Updates Shareholder Presentation</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-updates-shareholder-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-updates-shareholder-presentation</guid>
<pubDate>Thu, 01 Dec 2016 15:04:42 GMT</pubDate>
<description>AngioSoma, Inc. Updates Shareholder Presentation.</description>
</item>
<item>
<title>AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-acquires-patented-nutraceutical-for-muscle-mass-development</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-acquires-patented-nutraceutical-for-muscle-mass-development</guid>
<pubDate>Thu, 17 Nov 2016 14:49:12 GMT</pubDate>
<description>AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development.</description>
</item>
<item>
<title>AngioSoma, Inc. to Upgrade Its OmniCath Patents into OmniCath 2 Atherectomy Catheter</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-to-upgrade-its-omnicath-patents-into-omnicath-2-atherectomy-catheter</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-to-upgrade-its-omnicath-patents-into-omnicath-2-atherectomy-catheter</guid>
<pubDate>Fri, 04 Nov 2016 14:39:43 GMT</pubDate>
<description>AngioSoma, Inc. to Upgrade Its OmniCath Patents into OmniCath 2 Atherectomy Catheter.</description>
</item>
<item>
<title>Dr. Jackie R. See M.D. Joins AngioSoma, Inc.’s Scientific Advisory Board</title>
<link>https://6ix.com/company/angiosoma-inc/news/dr-jackie-r-see-md-joins-angiosoma-incs-scientific-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/dr-jackie-r-see-md-joins-angiosoma-incs-scientific-advisory-board</guid>
<pubDate>Thu, 20 Oct 2016 19:03:13 GMT</pubDate>
<description>Dr. Jackie R. See M.D. Joins AngioSoma, Inc.’s Scientific Advisory Board.</description>
</item>
<item>
<title>AngioSoma, Inc. Files 3 New Patent Applications on Liprostin™</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-files-3-new-patent-applications-on-liprostintm</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-files-3-new-patent-applications-on-liprostintm</guid>
<pubDate>Tue, 11 Oct 2016 13:13:41 GMT</pubDate>
<description>AngioSoma, Inc. Files 3 New Patent Applications on Liprostin™.</description>
</item>
<item>
<title>AngioSoma, Inc. Announces a Liprostin™ Focused Joint Venture</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-announces-a-liprostintm-focused-joint-venture</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-announces-a-liprostintm-focused-joint-venture</guid>
<pubDate>Wed, 05 Oct 2016 13:04:41 GMT</pubDate>
<description>AngioSoma, Inc. Announces a Liprostin™ Focused Joint Venture.</description>
</item>
<item>
<title>AngioSoma, Inc. Enters Discussions with Nutraceutical Intellectual Property Owners</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-enters-discussions-with-nutraceutical-intellectual-property-owners</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-enters-discussions-with-nutraceutical-intellectual-property-owners</guid>
<pubDate>Thu, 22 Sep 2016 13:05:11 GMT</pubDate>
<description>AngioSoma, Inc. Enters Discussions with Nutraceutical Intellectual Property Owners.</description>
</item>
<item>
<title>AngioSoma, Inc. Welcomes Dr. Tom Garcia to Scientific Advisory Board</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-welcomes-dr-tom-garcia-to-scientific-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosoma-inc-welcomes-dr-tom-garcia-to-scientific-advisory-board</guid>
<pubDate>Mon, 15 Aug 2016 22:37:50 GMT</pubDate>
<description>AngioSoma, Inc. Welcomes Dr. Tom Garcia to Scientific Advisory Board.</description>
</item>
<item>
<title>AngioSoma's Corporate Focus</title>
<link>https://6ix.com/company/angiosoma-inc/news/angiosomas-corporate-focus</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/angiosomas-corporate-focus</guid>
<pubDate>Thu, 14 Jul 2016 13:04:42 GMT</pubDate>
<description>AngioSoma's Corporate Focus.</description>
</item>
<item>
<title>FTTN: Investors Ignore Oil Slump, Keep Pouring Big Money into Energy Industry</title>
<link>https://6ix.com/company/angiosoma-inc/news/fttn-investors-ignore-oil-slump-keep-pouring-big-money-into-energy-industry</link>
<guid isPermaLink="true">https://6ix.com/company/angiosoma-inc/news/fttn-investors-ignore-oil-slump-keep-pouring-big-money-into-energy-industry</guid>
<pubDate>Thu, 25 Feb 2016 10:15:08 GMT</pubDate>
<description>FTTN: Investors Ignore Oil Slump, Keep Pouring Big Money into Energy Industry.</description>
</item>
</channel>
</rss>